Cargando…

Roles of IL-6-gp130 Signaling in Vascular Inflammation

Interleukin-6 (IL-6) is a well-established, independent indicator of multiple distinct types of cardiovascular disease and all-cause mortality. In this review, we present current understanding of the multiple roles that IL-6 and its signaling pathways through glycoprotein 130 (gp130) play in cardiov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Tieying, Tieu, Brian C, Ray, Sutapa, Recinos III, Adrian, Cui, Ruwen, Tilton, Ronald G, Brasier, Allan R
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers Ltd. 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780819/ https://www.ncbi.nlm.nih.gov/pubmed/19936194 http://dx.doi.org/10.2174/157340308785160570

Ejemplares similares

Requirement of histone deacetylase1 (HDAC1) in signal transducer and activator of transcription 3 (STAT3) nucleocytoplasmic distribution
por: Ray, Sutapa, et al.
Publicado: (2008)

Generation and characterization of a novel transgenic mouse harboring conditional nuclear factor-kappa B/RelA knockout alleles
por: Ijaz, Talha, et al.
Publicado: (2016)

IL‐6 Regulates Extracellular Matrix Remodeling Associated With Aortic Dilation in a Fibrillin‐1 Hypomorphic mgR/mgR Mouse Model of Severe Marfan Syndrome
por: Ju, Xiaoxi, et al.
Publicado: (2014)

IL-6/gp130 signaling: a key unlocking regeneration
por: Li, Ruopu, et al.
Publicado: (2023)

Multiple Myeloma and B Cell Lymphoma. Investigation of IL-6, IL-6 Receptor Antagonist (IL-6RA), and GP130 Antagonist (GP130A) Using Various Parameters in an In Vitro Model
por: Kovacs, Eva
Publicado: (2006)

Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man
por: Luchtefeld, Maren, et al.
Publicado: (2007)

The Role of gp130 Cytokines in Tuberculosis
por: Ritter, Kristina, et al.
Publicado: (2020)

A role for IL-27p28 as an antagonist of gp130-mediated signaling
por: Stumhofer, Jason S., et al.
Publicado: (2010)

Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer
por: Heo, Tae-Hwe, et al.
Publicado: (2016)

IL-6 Trans-signaling-STAT3 Pathway Mediates ECM and Cellular Proliferation in Fibroblasts from Hypertrophic Scar
por: Ray, Sutapa, et al.
Publicado: (2013)

The expression of IL-6Rα and Gp130 in fallopian tubes bearing an ectopic pregnancy
por: Yousefian, Elham, et al.
Publicado: (2013)

Exacerbated inflammatory arthritis in response to hyperactive gp130 signalling is independent of IL-17A
por: Jones, G W, et al.
Publicado: (2013)

Exclusive inhibition of IL-6 trans-signaling by soluble gp130(FlyR)Fc
por: Berg, Anna F., et al.
Publicado: (2021)

GP130 Cytokines in Breast Cancer and Bone
por: Omokehinde, Tolu, et al.
Publicado: (2020)

Interleukin-6 “Trans-Signaling” and Ischemic Vascular Disease: The Important Role of Soluble gp130
por: Morieri, Mario Luca, et al.
Publicado: (2017)

Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling
por: Wang, Yina, et al.
Publicado: (2017)

Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy
por: Xiao, Hui, et al.
Publicado: (2017)

The Signal Transducer IL6ST (gp130) as a Predictive and Prognostic Biomarker in Breast Cancer
por: Martínez-Pérez, Carlos, et al.
Publicado: (2021)

Gp130 Promotes Inflammation via the STAT3/JAK2 Pathway in Allergic Conjunctivitis
por: Bao, Jiayu, et al.
Publicado: (2023)

New insights into the role and signalling processes of gp130
por: Rose-John, Stefan
Publicado: (2011)

The two facets of gp130 signalling in liver tumorigenesis
por: Schmidt-Arras, Dirk, et al.
Publicado: (2021)

IL-6–GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver models
por: Carbonaro, Marisa, et al.
Publicado: (2023)

A GP130-Targeting Small Molecule, LMT-28, Reduces LPS-Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling
por: Liu, Qi-qi, et al.
Publicado: (2023)

Lack of Expression of Gp-130 Makes Pancreatic Beta Cell Lines Unresponsive to the IL-6 Family of Cytokines
por: Naselli, Gaetano, et al.
Publicado: (2000)

A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis
por: Schwerd, Tobias, et al.
Publicado: (2017)

The Dynamics of Signal Triggering in a gp130-Receptor Complex
por: Matadeen, Rishi, et al.
Publicado: (2007)

Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction
por: Ritschel, Vibeke N., et al.
Publicado: (2016)

Rapid monocyte infiltration following retinal detachment is dependent on non-canonical IL6 signaling through gp130
por: Wang, Xinlei, et al.
Publicado: (2017)

Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling
por: Pozios, Ioannis, et al.
Publicado: (2020)

Mononuclear cells from patients with rhupus are influenced by TNF in their production of gp130/sIL-6Rb and APRIL
por: Amezcua-Guerra, Luis M, et al.
Publicado: (2023)

Joint disease caused by defective gp130-mediated STAT signaling
por: Naka, Tetsuji, et al.
Publicado: (2002)

Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
por: Wei, Jia, et al.
Publicado: (2019)

Structural insights into the assembly of gp130 family cytokine signaling complexes
por: Zhou, Yi, et al.
Publicado: (2023)

Modulation of the IL-6-Signaling Pathway in Liver Cells by miRNAs Targeting gp130, JAK1, and/or STAT3
por: Servais, Florence A., et al.
Publicado: (2019)

The Alzheimer’s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130
por: Müller, Stephan A., et al.
Publicado: (2023)

Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor α to gp130 expression: fusing experimental insights and dynamic modelling
por: Reeh, Heike, et al.
Publicado: (2019)

Characterization of HZ0412a, a novel potent humanized anti-IL-6 receptor antibody that blocks IL-6R binding to gp130
por: Han, Jianzhong, et al.
Publicado: (2023)

Narrative-based computational modelling of the Gp130/JAK/STAT signalling pathway
por: Guerriero, Maria Luisa, et al.
Publicado: (2009)

Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model
por: Hatting, M, et al.
Publicado: (2015)

Correction to: Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
por: Wei, Jia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7jeb5cb7f0aj38n6lrdarlrrq3